Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-18

Clinical Trial Update: Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy and safety of semaglutide injection in adults with Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN